Skip to main content

Protagonist Therapeutics Inc

For the period ended Jun 20, 2025. Filed Apr 29, 2025.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Jun 20, 2025 · Filed Apr 29, 2025

PTGX$132.04-2.4%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

CODE OF ETHICS

The Company has adopted the Code of Business Conduct and Ethics (the “Code”) that applies to all officers, directors and employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. The Code is available in the

​

“Investors — Governance” section of the Company’s website atwww.protagonist-inc.com. If the Company makes certain amendments to the Code or grants any waiver of a provision of the Code to any executive officer or director, the Company intends to promptly disclose the nature of the amendment or waiver on its website, to the extent required by applicable rules.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.